Ameritas Investment Company, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Company, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$172,000
+36.5%
44,232
+12.7%
0.01%
+33.3%
Q2 2021$126,000
+425.0%
39,232
+263.9%
0.01%
+20.0%
Q4 2020$24,000
-27.3%
10,7820.0%0.01%
-50.0%
Q3 2020$33,0000.0%10,7820.0%0.01%
+11.1%
Q2 2020$33,000
+32.0%
10,782
-18.8%
0.01%
+125.0%
Q1 2020$25,000
-19.4%
13,282
+23.2%
0.00%
-42.9%
Q4 2019$31,00010,7820.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders